Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
Comunity acquired legionella pneumonia: cardiovascular events and survival Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020
Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database Source: Eur Respir J, 57 (2) 2002795; 10.1183/13993003.02795-2020 Year: 2021
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
COPD is an independent risk factor for mortality in community acquired pneumonia Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007
Preventing cardiovascular events after pneumonia with aspirin: one step forward, but still many to go Source: Eur Respir J, 57 (2) 2003778; 10.1183/13993003.03778-2020 Year: 2021
Community acquired pneumonia (CAP) and PSI mortality risk stratification Source: Eur Respir J 2004; 24: Suppl. 48, 413s Year: 2004
Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015
Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Vascular events following hospitalisation for community acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019 Year: 2019
The problem of early mortality in pneumococcal pneumonia: a study of risk factors Source: Eur Respir J 2015; 46: 561-564 Year: 2015
Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018
Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
COPD and respiratory viral infections as risk factors for the development of cardiovascular events Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020
Risk factors contributing to mortality in patients with COPD developing acute respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Admission hyperglycaemia is associated with increased risk of diabetes mellitus following hospitalisation with community acquired pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Risk factors for bacterial infection in exacerbated COPD requiring admission Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001
Potential causes of increased long-term mortality after pneumonia Source: Eur Respir J 2011; 37: 1306-1307 Year: 2011